biggest biotech private equity
Last year, Ramaswamy was behind the biggest U.S. biotech IPO ever when Roivantâs Axovant Sciences raised $360 million. Like Myovant, Axovant was a very young company that had only recently purchased its only asset, an experimental Alzheimerâs pill from GlaxoSmithKline.